[gpt3]Summarize this content to 100 words:
Programme aims to highlight recent advances in precision genomic medicine which has provided new insights into what constitutes disease
A workshop currently underway in Dublin will train ‘the next generation of genomic medicine leaders’, attendees have heard.
Clinicians and experts from 54 countries are currently taking part in a three-day educational programme in precision genomic medicine at the Mater Hospital, which concludes today.
The course aims to inform practitioners of the recent advances in genomic medicine, which have led to an explosion of new information on what constitutes disease.
As a result of these breakthroughs, informed clinicians and scientists are now in a position to make accurate diagnoses, and potentially provide targeted therapies to their patients according to well-defined, biologically-informed disease subtypes, accounting for individual differences in genetic make-up, behaviours, cultures, lifestyles and the environment.
“This course unites experts, researchers, clinicians and educators from across the world to train the next generation of genomic medicine leaders,” said Mater Hospital CEO Josephine Ryan Leacy.
“The Mater Hospital is proud to be at the forefront of this transformative movement in healthcare, where collaboration and clinical application drive real-world impact.”
The workshop has brought together more than 20 leading international educators and clinicians to deliver practical, evidence-based insights on the implementation of genomic medicine in acute and routine care.
The programme will discuss how genomic medicine clinical utility can be delivered across rare disease, cancer, and common conditions.
Other topics covered include gene/genotype directed therapies; ethics and data governance; the integration of artificial intelligence into diagnostics; and multidisciplinary clinical pathways.
“As the field of genomics continues to shift from a theoretical science to a cornerstone of modern healthcare, this event will accelerate knowledge-sharing and upskilling of healthcare professionals using genetics and genomics in their clinical work and foster meaningful international collaboration in precision genomics,” said Dr James O’Byrne, consultant clinical geneticist and metabolic physician at the Mater Hospital.
Developed in partnership with the European Society of Human Genetics (ESHG), the Canadian College of Medical Geneticists (CCMG), and the Human Genetics Society of Australasia (HGSA), this is the first time all three organisations have collaborated on a global workshop.
Taking place in the Mater’s Pillar Centre for Transformative Healthcare, the workshop’s organisers hope that international attendees will bring new information and an improved understanding of genomic medicine to their home countries all over the world.
A total of 16 scholarships were awarded to international clinicians and scientists from disadvantaged nations to take part, and 54 countries are represented across attendees and expert speakers.
[/gpt
Source link